Increased level of carcinoembryonal antigen is not primarily a marker for ovarian cancer
Kristensen, C.Andrup.; Roed, H.M.H.
Ugeskrift for Laeger 167(2): 189; Author Reply 190
2005
ISSN/ISBN: 0041-5782 PMID: 15697136 Document Number: 587860
Document emailed within 1 workday
Related Documents
Lang, B.A.; Kocent, A.; Nekulová, M.; Hlávková, J. 1984: Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer Neoplasma 31(1): 79-87Sier, C.F.; Stephens, R.; Bizik, J.; Mariani, A.; Bassan, M.; Pedersen, N.; Frigerio, L.; Ferrari, A.; Danø, K.; Brünner, N.; Blasi, F. 1998: The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients Cancer Research 58(9): 1843-1849
Nakagoe, T.; Sawai, T.; Tsuji, T.; Jibiki, M.; Ohbatake, M.; Nanashima, A.; Yamaguchi, H.; Kurosaki, N.; Yasutake, T.; Ayabe, H.; Arisawa, K. 2001: Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer Journal of Experimental and Clinical Cancer Research: Cr 20(1): 85-90
Ruoslahti, E.; Seppälä, M. 1972: Alpha-fetoprotein--a carcinoembryonal antigen Duodecim; Laaketieteellinen Aikakauskirja 88(17): 1033-1043
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Wojciechowska-Lacka, A.; Markowska, J.; Skasko, E.; Kruczek, A.; Steffen, J. 2003: Frequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report) European Journal of Gynaecological Oncology 24(1): 21-24
Gärtner, H.; Maier, K.P. 2005: Increased carcinoembryonic antigen level: which diagnosis? Deutsche Medizinische Wochenschrift 130(7): 353
Auer, I.O.; Münch, L.; Schmid, L. 1976: The value of the concentration of carcinoembryonal antigen (CEA) in the plasma in first diagnoses and course control of treated gastrointestinal neoplasms Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 1016-1020
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Takahashi, K.; Hiramatsu, K.; Kawakita, M.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Tamamori, Y. 2004: The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 332-335
Nozawa, S.; Aoki, D.; Yajima, M.; Tsukazaki, K.; Kobayashi, T.; Kimura, E.; Terashima, Y.; Inaba, N.; Takamizawa, H.; Negishi, Y. 1992: CA54/61 as a marker for epithelial ovarian cancer Cancer Research 52(5): 1205-1209
Jurcuţ, C.; Filişan, C.; Popovici, C.; Toma, L.; Panaite, B.; Nicodin, O.; Copaci, I. 2009: Young woman with polyserositis, ovarian cystic mass and increased level of CA-125. Case report of peritoneal and pleural tuberculosis Romanian Journal of Internal Medicine 47(3): 297-299
Hu, H.; Li, C.; Cai, S.; Zhu, C.; Tian, Y.; Zheng, J.; Hu, J.; Chen, C.; Liu, W. 2014: Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer Hepato-Gastroenterology 61(133): 1478-1482
Harada, H.; Takanashi, N.; Tsukada, Y.; Takahashi, M.; Kimura, E.; Terashima, Y.; Nakamura, H.; Takahashi, E.; Hayata, Y. 1989: Detection of a novel antigen (1G12) on the surface of peripheral blood mononuclear cells from cancer patients by a sensitive radioimmunoassay. A possible marker for the early diagnosis of cancer Japanese Journal of Experimental Medicine 59(6): 215-220
Narita, D.; Cimpean, A.M.; Anghel, A.; Raica, M. 2006: Prostate-specific antigen value as a marker in breast cancer Neoplasma 53(2): 161-167
Bodnar, L.; Wcisło, G.B.; elichowski, G.; Raczka, A.; Wańkowicz, Z.; Szczylik, C. 2008: Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 307-311
Pathak, K.A.; Khanna, R.; Khanna, H.D.; Khanna, S.; Gupta, S.; Khanna, N.N. 1996: Carcinoembryonic antigen: an invaluable marker for advanced breast cancer Journal of Postgraduate Medicine 42(3): 68-71
Fan, R.; Huang, W.; Luo, B.; Zhang, Q.M.; Xiao, S.W.; Xie, X.X. 2015: Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays European Journal of Gynaecological Oncology 36(3): 298-303
Suzuki, M.; Sekiguchi, I.; Ohwada, M.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. (IV) Serum CA 125 levels through normal menstrual cycle and in benign diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 285-288
Roumeguere, T.; Zlotta, A.R.; Djavan, B.R.; Marberger, M.; Schulman, C.C. 1997: PSA level of the transitional zone: a new marker especially reliable for the detection of prostatic cancer Acta Urologica Belgica 65(1): 5-9